Search Thermo Fisher Scientific
Element Search
Structure Search
Thermo Scientific Chemicals
Ciprofloxacin hydrochloride monohydrate
An anti-bacterial agent effective against anaerobic bacteria | CAS: 86393-32-0 | C17H21ClFN3O4 | 385.82 g/mol
Have Questions?
Change view
Catalog number ALFJ61970.14
View Price:Sign InSign in to see your account pricing. Need an account? Register with us today.
Quantity:
25 g
Specifications
Chemical Name or MaterialCiprofloxacin hydrochloride
TypeCiprofloxacin Hydrochloride
Physical FormLyophilized Powder
CAS86393-32-0
Recommended StorageStore at -20°C
View more
Ciprofloxacin hydrochloride has been suggested as a treatment for a wide range of infections caused by susceptible organisms including infections of urinary, respiratory, and gastrointestinal tracts, gonorrhoea and septicaemia. Nalidixic acid analogue.
This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.
Applications
Ciprofloxacin hydrochloride has been suggested as a treatment for a wide range of infections caused by susceptible organisms including infections of urinary, respiratory, and gastrointestinal tracts, gonorrhoea and septicaemia. May be given by mouth or may be administered by intravenous infusion. Nalidixic acid analogue.
Solubility
Soluble in water (35mg/ml).
Notes
Research Use only: Not intended for animal or human diagnostic or therapeutic use.
Ciprofloxacin hydrochloride has been suggested as a treatment for a wide range of infections caused by susceptible organisms including infections of urinary, respiratory, and gastrointestinal tracts, gonorrhoea and septicaemia. May be given by mouth or may be administered by intravenous infusion. Nalidixic acid analogue.
Solubility
Soluble in water (35mg/ml).
Notes
Research Use only: Not intended for animal or human diagnostic or therapeutic use.
RUO – Research Use Only
General References:
- D.C. Hooper, et al. Mechanisms of action of and resistance to ciprofloxacin. Am. J. Med. 1987, 82, (4A), 12-20.
- R.K. Shandil, et al. Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy. Antimicrob. Agents Chemother. 2007, 51, (2), 576-582.